Dianthus Therapeutics Inc. (DNTH) — Long-term Investment Intensity
Dianthus Therapeutics Inc. (DNTH) has a Long-term Investment Intensity of 20.7% as of December 2025. Long-term investments of $110.14 Million represent 20.7% of total assets of $530.92 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Dianthus Therapeutics Inc. (DNTH) net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Dianthus Therapeutics Inc. Long-term Investment Intensity (2024–2025)
This chart shows how Dianthus Therapeutics Inc.'s Long-term Investment Intensity has evolved across 2 annual periods from 2024 to 2025. As of December 2025, the intensity stands at 20.7%, reflecting long-term investments of $110.14 Million against total assets of $530.92 Million USD. Also explore Dianthus Therapeutics Inc. balance sheet assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Dianthus Therapeutics Inc. (2024–2025)
The table below presents the year-by-year Long-term Investment Intensity for Dianthus Therapeutics Inc. from 2024 to 2025, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Dianthus Therapeutics Inc. (DNTH) market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 20.7% | $110.14 Million | $530.92 Million | ▼ -1.1 pp |
| 2024 | 21.9% | $81.73 Million | $374.01 Million | — |